Beyond neurological disease: New targets for edaravone (Review)

International Journal of Molecular Medicine

Volumn 28, Issue 6, 2011, Pages 899-906

  Kikuchi, Kiyoshi ^a   Uchikado, Hisaaki ^b   Miyagi, Naohisa ^a   Morimoto, Yoko ^c   Takashi, Ito ^c   Tancharoen, Salunya ^d   Miura, Naoki ^e   Miyata, Kie ^c   Sakamoto, Rokudai ^a   Kikuchi, Chiemi ^f   Iida, Narumi ^g   Shiomi, Naoto ^h   Kuramoto, Terukazu ⁱ   Kawahara, K Ichi ^c  

^a Yame Public General Hospital   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KAGOSHIMA UNIVERSITY   (Japan)

^d MAHIDOL UNIVERSITY   (Thailand)

^e KAGOSHIMA UNIVERSITY   (Japan)

^f Nishida Koutoku Hospital   (Japan)

^g Research Laboratory   (Japan)

^h Medical Care Center   (Japan)

ⁱ Omuta City General Hospital   (Japan)

Author keywords

Cerebral infarction; Edaravone; Free radical scavenger; Non neurological disease

Indexed keywords

NORPHENAZONE; TOXIN;

BLADDER INJURY; BRAIN INFARCTION; BURN; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG TARGETING; HEART MUSCLE INJURY; HEART PROTECTION; HEMORRHAGIC SHOCK; HUMAN; INTESTINE INJURY; KIDNEY INJURY; LIVER INJURY; LIVER PROTECTION; LUNG INJURY; NEUROLOGIC DISEASE; NONHUMAN; PANCREAS INJURY; PRIORITY JOURNAL; RADIATION INJURY; RENAL PROTECTION; REVIEW; SEPSIS; TESTIS INJURY;

ANIMALS; ANTIPYRINE; APOPTOSIS; CARDIOVASCULAR DISEASES; FREE RADICAL SCAVENGERS; FREE RADICALS; HEART; HUMANS; LIVER; LUNG; MICE; NECROSIS; NITRIC OXIDE; OXIDATIVE STRESS; PANCREAS; RATS; WOUNDS AND INJURIES;

EID: 80053510027     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2011.795     Document Type: Review

References (100)

1. Adams HP Jr, del Zoppo G, Alberts MJ, et al: Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 38: 1655-1711, 2007. (Pubitemid 46691097)
2. Watanabe T, Yuki S, Egawa M and Nishi H: Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions. J Pharmacol Exp Ther 268: 1597-1604, 1994. (Pubitemid 24100383)
3. Yoneda Y, Uehara T, Yamasaki H, Kita Y, Tabuchi M and Mori E: Hospital-based study of the care and cost of acute ischemic stroke in Japan. Stroke 34: 718-724, 2003. (Pubitemid 36307400)
4. Wang CX and Shuaib A: Neuroprotective effects of free radical scavengers in stroke. Drugs Aging 24: 537-546, 2007. (Pubitemid 47195673)
5. Green AR and Shuaib A: Therapeutic strategies for the treatment of stroke. Drug Discov Today 11: 681-693, 2006. (Pubitemid 44056287)
6. Van der Worp HB, Kappelle LJ, Algra A, et al: The effect of tirilazad mesylate on infarct volume of patients with acute ischemic stroke. Neurology 58: 133-135, 2002. (Pubitemid 34041952)
7. Shuaib A, Lees KR, Lyden P, et al: NXY-059 for the treatment of acute ischemic stroke. N Engl J Med 357: 562-571, 2007. (Pubitemid 47236281)
8. Edaravone Acute Brain Infarction Study Group: Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters. Cerebrovasc Dis 15: 222-229, 2003.
9. Zhang N, Komine-Kobayashi M, Tanaka R, Liu M, Mizuno Y and Urabe T: Edaravone reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal ischemia in mice brain. Stroke 36: 2220-2225, 2005. (Pubitemid 41429250)
10. Unno Y, Katayama M and Shimizu H: Does functional outcome in acute ischaemic stroke patients correlate with the amount of free-radical scavenger treatment? A retrospective study of edaravone therapy. Clin Drug Investig 30: 143-155, 2010.
11. Kikuchi K, Kawahara K, Tancharoen S, et al: The free radical scavenger edaravone rescues rats from cerebral infarction by attenuating the release of high-mobility group box-1 in neuronal cells. J Pharmacol Exp Ther 329: 865-874, 2009.
12. Higashi Y, Jitsuiki D, Chayama K and Yoshizumi M: Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a novel free radical scavenger, for treatment of cardiovascular diseases. Recent Pat Cardiovasc Drug Discov 1: 85-93, 2006.
13. Yoshida H, Yanai H, Namiki Y, Fukatsu-Sasaki K, Furutani N and Tada N: Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury. CNS Drug Rev 12: 9-20, 2006. (Pubitemid 44133577)
14. Onogi H, Minatoguchi S, Chen XH, et al: Edaravone reduces myocardial infarct size and improves cardiac function and remodelling in rabbits. Clin Exp Pharmacol Physiol 33: 1035-1041, 2006. (Pubitemid 44581564)
15. Jolly SR, Kane WJ, Bailie MB, Abrams GD and Lucchesi BR: Canine myocardial reperfusion injury. Its reduction by the combined administration of superoxide dismutase and catalase. Circ Res 54: 277-285, 1984. (Pubitemid 14172438)
16. Nakamura Y, Yamada Y, Shimomura H, et al: The effect of edaravone on plasma monocyte chemoattractant protein-1 levels in patients with acute myocardial infarction. J Cardiol 54: 416-424, 2009.
17. Tsujita K, Shimomura H, Kaikita K, et al: Long-term efficacy of edaravone in patients with acute myocardial infarction. Circ J 70: 832-837, 2006. (Pubitemid 43979118)
18. Tsujita K, Shimomura H, Kawano H, et al: Effects of edaravone on reperfusion injury in patients with acute myocardial infarction. Am J Cardiol 94: 481-484, 2004. (Pubitemid 39120000)
19. Kotani Y, Ishino K, Osaki S, et al: Efficacy of MCI-186, a freeradical scavenger and antioxidant, for resuscitation of non-beating donor hearts. J Thoracic Cardiovasc Surg 133: 1626-1632, 2007. (Pubitemid 46802622)
20. Yamazaki K, Miwa S, Toyokuni S, et al: Effect of edaravone, a novel free radical scavenger, supplemented to cardioplegia on myocardial function after cardioplegic arrest: in vitro study of isolated rat heart. Heart Vessels 24: 228-235, 2009.
21. Minhaz U, Tanaka M, Tsukamoto H, et al: Effect of MCI-186 on postischemic reperfusion injury in isolated rat heart. Free Rad Res 24: 361-367, 1996. (Pubitemid 26181778)
22. Wu TW, Zeng LH, Wu J and Fung KP: Myocardial protection of MCI-186 in rabbit ischemia-reperfusion. Life Sci 71: 2249-2255, 2002. (Pubitemid 35246213)
23. Yagi H, Horinaka S and Matsuoka H: Edaravone prevented deteriorated cardiac function after myocardial ischemia-reperfusion via inhibiting lipid peroxidation in rat. J Cardiovasc Pharmacol 46: 46-51, 2005. (Pubitemid 40917778)
24. Rajesh KG, Sasaguri S, Suzuki R and Maeda H: Antioxidant MCI-186 inhibits mitochondrial permeability transition pore and upregulates Bcl-2 expression. Am J Physiol Heart Circ Physiol 285: H2171-H2178, 2003. (Pubitemid 37305962)
25. Onimaru S, Nakamura K, Kariyazono H, et al: Inhibitory effects of edaravone on the production of tumor necrosis factor-alpha in the isolated heart undergoing ischemia and reperfusion. Heart Vessels 21: 108-115, 2006.
26. Sukmawan R, Yada T, Toyota E, et al: Edaravone preserves coronary microvascular endothelial function after ischemia/reperfusion on the beating canine heart in vivo. J Pharmacol Sci 104: 341-348, 2007. (Pubitemid 47378422)
27. Yamawaki M, Sasaki N, Shimoyama M, et al: Protective effect of edaravone against hypoxia-reoxygenation injury in rabbit cardiomyocytes. Br J Pharmacol 142: 618-626, 2004. (Pubitemid 38869876)
28. Belch JJ, Bridges AB, Scott N and Chopra M: Oxygen free radicals and congestive heart failure. Br Heart J 65: 245-248, 1991.
29. Kodama M, Matsumoto Y, Fujiwara M, Masani F, Izumi T and Shibata A: A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction. Clin Immunol Immunopathol 57: 250-262, 1990. (Pubitemid 20368038)
30. Okabe TA, Kishimoto C, Hattori M, Nimata M, Shioji K and Kita T: Cardioprotective effects of 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186), a novel free radical scavenger, on acute autoimmune myocarditis in rats. Exp Clin Cardiol 9: 177-180, 2004. (Pubitemid 39600018)
31. Nimata M, Okabe TA, Hattori M, Yuan Z, Shioji K and Kishimoto C: MCI-186 (edaravone), a novel free radical scavenger, protects against acute autoimmune myocarditis in rats. Am J Physiol Heart Circ Physiol 289: H2514-H2518, 2005. (Pubitemid 41698566)
32. Shimazaki H, Watanabe K, Veeraveedu PT, et al: The antioxidant edaravone attenuates ER-stress-mediated cardiac apoptosis and dysfunction in rats with autoimmune myocarditis. Free Radic Res 44: 1082-1090, 2010.
33. Akao T, Takeyoshi I, Totsuka O, et al: Effect of the free radical scavenger MCI-186 on pulmonary ischemia-reperfusion injury in dogs. J Heart Lung Transplant 25: 965-971, 2006. (Pubitemid 44143001)
34. Qiu W, Gu H, Zheng L, Zhou J, Chen D and Chen Y: Pretreatment with edaravone reduces lung mitochondrial damage in an infant rabbit ischemia-reperfusion model. J Pediatr Surg 43: 2053-2060, 2008.
35. Reyes YA, Shimoyama T, Akamatsu H and Sunamori M: MCI-186 (edaravone), a free radical scavenger, attenuates ischemiareperfusion injury and activation of phospholipase A(2) in an isolated rat lung model after 18 h of cold preservation. Eur J Cardiothorac Surg 29: 304-311, 2006. (Pubitemid 43207568)
36. Tajima S, Soda M, Bando M, et al: Preventive effects of edaravone, a free radical scavenger, on lipopolysaccharide-induced lung injury in mice. Respirology 13: 646-653, 2008. (Pubitemid 351977593)
37. Asai T, Ohno Y, Minatoguchi S, et al: The specific free radical scavenger edaravone suppresses bleomycin-induced acute pulmonary injury in rabbits. Clin Exp Pharmacol Physiol 34: 22-26, 2007. (Pubitemid 46069581)
38. Tajima S, Bando M, Ishii Y, et al: Effects of edaravone, a free-radical scavenger, on bleomycin-induced lung injury in mice. Eur Respir J 32: 1337-1343, 2008.
39. Newman TS, Magnuson TH, Ahrendt SA, Smith-Meek MA and Bender JS: The changing face of mesenteric infarction. Am Surg 64: 611-616, 1998. (Pubitemid 28294684)
40. Haglund U, Bulkley GB and Granger DN: On the pathophysiology of intestinal ischemic injury. Clinical review. Acta Chir Scand 153: 321-324, 1987.
41. Sonoda A, Nitta N, Seko A, et al: Edaravone prevents bowel infarction after acute superior mesenteric artery thromboembolism using autologous fibrin clots in a rabbit model. Br J Radiol 82: 711-715, 2009.
42. Tomatsuri N, Yoshida N, Takagi T, et al: Edaravone, a newly developed radical scavenger, protects against ischemia-reperfusion injury of the small intestine in rats. Int J Mol Med 13: 105-109, 2004.
43. Canavan C, Abrams KR and Mayberry J: Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease. Aliment Pharmacol Ther 23: 1097-1104, 2006. (Pubitemid 43779348)
44. Shimizu K, Koga H, Iida M and Haruma K: Microcirculatory changes in experimental mesenteric longitudinal ulcers of the small intestine in rats. Dig Dis Sci 52: 3019-3028, 2007. (Pubitemid 47512561)
45. Day HL and Taylor RM: The liver. Part 5: acute liver failure. Nurs Times 102: 26-27, 2006.
46. Ito K, Ozasa H, Noda Y, Arii S and Horikawa S: Effects of free radical scavenger on acute liver injury induced by d-galactosamine and lipopolysaccharide in rats. Hepatol Res 38: 194-201, 2008.
47. Brattin WJ, Glende EA Jr and Recknagel RO: Pathological mechanisms in carbon tetrachloride hepatotoxicity. J Free Radic Biol Med 1: 27-38, 1985. (Pubitemid 16104819)
48. Comporti M: Lipid peroxidation and cellular damage in toxic liver injury. Lab Invest 53: 599-623, 1985.
49. Kono H, Asakawa M, Fujii H, et al: Edaravone, a novel free radical scavenger, prevents liver injury and mortality in rats administered endotoxin. J Pharmacol Exp Ther 307: 74-82, 2003. (Pubitemid 37151893)
50. Tsuji K, Kwon AH, Yoshida H, et al: Free radical scavenger (edaravone) prevents endotoxin-induced liver injury after partial hepatectomy in rats. J Hepatol 42: 94-101, 2005. (Pubitemid 40038906)
51. Hiranuma S, Ito K, Noda Y, Ozasa H, Koike Y and Horikawa S: Amelioration of hepatic ischemia/reperfusion injury in the remnant liver after partial hepatectomy in rats. J Gastroenterol Hepatol 22: 2167-2172, 2007. (Pubitemid 350145616)
52. Kono H, Woods CG, Maki A, et al: Electron spin resonance and spin trapping technique provide direct evidence that edaravone prevents acute ischemia-reperfusion injury of the liver by limiting free radical-mediated tissue damage. Free Radic Res 40: 579-588, 2006. (Pubitemid 43832512)
53. Nakamura A, Akamatsu Y, Miyagi S, Fukumori T, Sekiguchi S and Satomi S: A free radical scavenger, edaravone, prevents ischemia-reperfusion injury in liver grafts from non-heart-beating donors. Transplant Proc 40: 2171-2174, 2008.
54. Ninomiya M, Shimada M, Harada N, et al: Beneficial effect of MCI-186 on hepatic warm ischemia-reperfusion in the rat. Transplantation 74: 1470-1472, 2002. (Pubitemid 35379556)
55. Ninomiya M, Shimada M, Harada N, Soejima Y, Suehiro T and Maehara Y: The hydroxyl radical scavenger MCI-186 protects the liver from experimental cold ischaemia-reperfusion injury. Br J Surg 91: 184-190, 2004. (Pubitemid 38233963)
56. Okatani Y, Wakatsuki A, Enzan H and Miyahara Y: Edaravone protects against ischemia/reperfusion-induced oxidative damage to mitochondria in rat liver. Eur J Pharmacol 465: 163-170, 2003. (Pubitemid 36332289)
57. Suzuki F, Hashikura Y, Ise H, et al: MCI-186 (edaravone), a free radical scavenger, attenuates hepatic warm ischemia-reperfusion injury in rats. Transpl Int 18: 844-853, 2005. (Pubitemid 41726816)
58. Taniguchi M, Uchinami M, Doi K, et al: Edaravone reduces ischemia-reperfusion injury mediators in rat liver. J Surg Res 137: 69-74, 2007. (Pubitemid 44879433)
59. Nakamoto N, Tada S, Kameyama K, et al: A free radical scavenger, edaravone, attenuates steatosis and cell death via reducing inflammatory cytokine production in rat acute liver injury. Free Radic Res 37: 849-859, 2003. (Pubitemid 36939601)
60. Tada S, Nakamoto N, Kameyama K, et al: Clinical usefulness of edaravone for acute liver injury. J Gastroenterol Hepatol 18: 851-857, 2003. (Pubitemid 36936579)
61. Miyasou T, Kwon AH, Tsuji K, Qiu Z, Okumura T and Kamiyama Y: Edaravone prevents Fas-induced fulminant hepatic failure in mice by regulating mitochondrial Bcl-xL and Bax. Shock 30: 212-216, 2008.
62. Thurman RG, Marzi I, Seitz G, Thies J, Lemasters JJ and Zimmerman F: Hepatic reperfusion injury following orthotopic liver transplantation in the rat. Transplantation 46: 502-506, 1988.
63. Yoshida H, Kwon AH, Habara K, et al: Edaravone inhibits the induction of iNOS gene expression at transcriptional and posttranscriptional steps in murine macrophages. Shock 30: 734-739, 2008.
64. Eland IA, Sturkenboom MJ, Wilson JH and Stricker BH: Incidence and mortality of acute pancreatitis between 1985 and 1995. Scand J Gastroenterol 35: 1110-1116, 2000.
65. Leung PS and Chan YC: Role of oxidative stress in pancreatic inflammation. Antioxid Redox Signal 11: 135-165, 2009.
66. Rao P, Maeda H, Yutong X, Yamamoto M, Hirose N and Sasaguri S: Protective effect of a radical scavenger, MCI-186 on islet cell damages induced by oxidative stress. Transplant Proc 37: 3457-3458, 2005. (Pubitemid 41659920)
67. Araki Y, Andoh A, Yokono T, et al: The free radical scavenger edaravone suppresses experimental closed duodenal loop-induced acute pancreatitis in rats. Int J Mol Med 12: 121-124, 2003.
68. Yang T, Mao YF, Liu SQ, et al: Protective effects of the free radical scavenger edaravone on acute pancreatitis-associated lung injury. Eur J Pharmacol 630: 152-157, 2010.
69. Fukudome D, Matsuda M, Kawasaki T, Ago Y and Matsuda T: The radical scavenger edaravone counteracts diabetes in multiple low-dose streptozotocin-treated mice. Eur J Pharmacol 583: 164-169, 2008.
70. Nagatani S, Sudo T, Murakami Y, Uemura K, Hiyama E and Sueda T: Edaravone, a free radical scavenger, promotes engraftment of intraportally transplanted islet cells. Pancreas 40: 126-130, 2011.
71. Shino Y, Itoh Y, Kubota T, Yano T, Sendo T and Oishi R: Role of poly(ADP-ribose)polymerase in cisplatin-induced injury in LLC-PK1 cells. Free Radic Biol Med 35: 966-977, 2003. (Pubitemid 37211451)
72. Satoh M, Kashihara N, Fujimoto S, et al: A novel free radical scavenger, edarabone, protects against cisplatin-induced acute renal damage in vitro and in vivo. J Pharmacol Exp Ther 305: 1183-1190, 2003. (Pubitemid 36617997)
73. Iguchi T, Nishikawa M, Chang B, et al: Edaravone inhibits acute renal injury and cyst formation in cisplatin-treated rat kidney. Free Radic Res 38: 333-341, 2004. (Pubitemid 38455857)
74. Sueishi K, Mishima K, Makino K, et al: Protection by a radical scavenger edaravone against cisplatin-induced nephrotoxicity in rats. Eur J Pharmacol 451: 203-208, 2002. (Pubitemid 35253961)
75. Doi K, Suzuki Y, Nakao A, Fujita T and Noiri E: Radical scavenger edaravone developed for clinical use ameliorates ischemia/reperfusion injury in rat kidney. Kidney Int 65: 1714-1723, 2004. (Pubitemid 38591019)
76. Matsuyama M, Hayama T, Funao K, et al: Treatment with edaravone improves the survival rate in renal warm ischemia-reperfusion injury using rat model. Transplant Proc 38: 2199-2200, 2006. (Pubitemid 46068500)
77. Tahara M, Nakayama M, Jin MB, et al: A radical scavenger, edaravone, protects canine kidneys from ischemia-reperfusion injury after 72 hours of cold preservation and autotransplantation. Transplantation 80: 213-221, 2005. (Pubitemid 41061678)
78. Someya T, Kaneko K, Yamada T and Yamashiro Y: Effect of a novel free radical scavenger, edaravone, on puromycin amino-nucleoside induced nephrosis in rats. Pediatr Nephrol 20: 1430-1434, 2005. (Pubitemid 41403418)
79. Matsumura H, Ashida A, Hirano K, Nakakura H and Tamai H: Protective effect of radical scavenger edaravone against puromycin nephrosis. Clin Nephrol 66: 405-410, 2006. (Pubitemid 44896148)
80. Kaneko K, Yonemitsu Y, Fujii T, et al: A free radical scavenger but not FGF-2-mediated angiogenic therapy rescues myonephropathic metabolic syndrome in severe hindlimb ischemia. Am J Physiol 290: H1484-H1492, 2006.
81. Cristol JP, Vela C, Maggi MF, Descomps B and Mourad G: Oxidative stress and lipid abnormalities in renal transplant recipients with or without chronic rejection. Transplantation 65: 1322-1328, 1998. (Pubitemid 28283093)
82. Minz M, Heer M, Arora S, Sharma A and Khullar M: Oxidative status in stable renal transplantation. Transplant Proc 38: 2020-2021, 2006. (Pubitemid 46068550)
83. Matsumoto S, Hanai T, Yoshioka N, et al: Edaravone protects against ischemia/reperfusion-induced functional and biochemical changes in rat urinary bladder. Urology 66: 892-896, 2005. (Pubitemid 41440863)
84. Shimizu S, Saito M, Kinoshita Y, et al: Acute urinary retention and subsequent catheterization cause lipid peroxidation and oxidative DNA damage in the bladder: preventive effect of edaravone, a free-radical scavenger. BJU Int 104: 713-717, 2009.
85. Tamamura M, Saito M, Kinoshita Y, et al: Protective effect of edaravone, a free-radical scavenger, on ischaemia-reperfusion injury in the rat testis. BJU Int 105: 870-876, 2010.
86. Martin GS, Mannino DM, Eaton S and Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348: 1546-1554, 2003. (Pubitemid 36437931)
87. Fernandes D and Assreuy J: Nitric oxide and vascular reactivity in sepsis. Shock 30 (Suppl 1): S10-S13, 2008.
88. Riedemann NC, Guo RF and Ward PA: Novel strategies for the treatment of sepsis. Nat Med 9: 517-524, 2003. (Pubitemid 36597096)
89. Victor VM, Rocha M, Esplugues JV and De la Fuente M: Role of free radicals in sepsis: antioxidant therapy. Curr Pharm Des 11: 3141-3158, 2005. (Pubitemid 41149930)
90. Wang H, Liao H, Ochani M, et al: Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 10: 1216-1221, 2004. (Pubitemid 39540438)
91. Kato S, Hussein MH, Kakita H, et al: Edaravone, a novel free radical scavenger, reduces high-mobility group box 1 and prolongs survival in a neonatal sepsis model. Shock 32: 586-592, 2009.
92. Saibara T, Toda K, Wakatsuki A, Ogawa Y, Ono M and Onishi S: Protective effect of 3-methyl-1-phenyl-2-pyrazolin-5-one, a free radical scavenger, on acute toxicity of paraquat in mice. Toxicol Lett 143: 51-54, 2003. (Pubitemid 36412172)
93. Kawasaki T, Ishihara K, Ago Y, et al: Protective effect of the radical scavenger edaravone against methamphetamine-induced dopaminergic neurotoxicity in mouse striatum. Eur J Pharmacol 542: 92-99, 2006. (Pubitemid 44066362)
94. Brigham PA and McLoughlin E: Burn incidence and medical care use in the United States: estimates, trends, and data sources. J Burn Care Rehabil 17: 95-107, 1996. (Pubitemid 26099431)
95. Koizumi T, Tanaka H, Sakaki S and Shimazaki S: The therapeutic efficacy of edaravone in extensively burned rats. Arch Surg 141: 992-995, 2006. (Pubitemid 44583256)
96. Sasano N, Enomoto A, Hosoi Y, et al: Free radical scavenger edaravone suppresses x-ray-induced apoptosis through p53 inhibition in MOLT-4 cells. J Radiat Res 48: 495-503, 2007. (Pubitemid 350211126)
97. Sasano N, Enomoto A, Hosoi Y, et al: Edaravone, a known free radical scavenger, enhances X-ray-induced apoptosis at low concentrations. Cancer Lett 293: 52-57, 2010.
98. Mori T, Yamamoto H, Tabata T, et al: A free radical scavenger, edaravone (MCI-186), diminishes intestinal neutrophil lipid peroxidation and bacterial translocation in a rat hemorrhagic shock model. Crit Care Med 33: 1064-1069, 2005. (Pubitemid 40638181)
99. Tharakan B, Hunter FA, Smythe WR and Childs EW: Curcumin inhibits reactive oxygen species formation and vascular hyperpermeability following haemorrhagic shock. Clin Exp Pharmacol Physiol 37: 939-944, 2010.
100. Uji Y, Yamamoto H, Mori T, et al: Edaravone improves the survival of rats subjected to hemorrhagic shock without resuscitation. Surg Today 38: 476-477, 2008. (Pubitemid 351624453)